Scientists give healthy men first doses of new drug to check safety
NCT ID NCT06721091
Summary
This was the first-ever study in people for a new oral drug called VNA-318. Its main goal was to check the safety and see how the body processes the drug in healthy male volunteers. Researchers tested single and multiple doses on 92 men to find a safe dose range for future studies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Biotrial
Rennes, 35000, France
Conditions
Explore the condition pages connected to this study.